BHC
Bausch Health Companies IncNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.14B
P/E Ratio
—
EPS
$-3.24
Beta
0.40
52W High
$8.69
52W Low
$4.41
50-Day MA
$5.51
200-Day MA
$6.37
Dividend Yield
—
Profit Margin
1.53%
Forward P/E
1.28
PEG Ratio
0.01
About Bausch Health Companies Inc
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
Fundamentals
| Revenue (TTM) | $10.27B |
| Gross Profit (TTM) | $7.25B |
| EBITDA | $3.40B |
| Operating Margin | 25.80% |
| Return on Equity | 43.60% |
| Return on Assets | 5.18% |
| Revenue/Share (TTM) | $27.68 |
| Book Value | $-1.50 |
| Price-to-Book | 18.78 |
| Price-to-Sales (TTM) | 0.21 |
| EV/Revenue | 2.107 |
| EV/EBITDA | 6.80 |
| Quarterly Earnings Growth (YoY) | 1368.00% |
| Quarterly Revenue Growth (YoY) | 9.30% |
| Shares Outstanding | $373.46M |
| Float | $258.51M |
| % Insiders | 30.41% |
| % Institutions | 64.98% |
Historical Volatility
HV 10-Day
29.66%
HV 20-Day
33.44%
HV 30-Day
37.11%
HV 60-Day
39.38%
HV Rank
11.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.57 target)
1
Strong Buy8
HoldData last updated: 5/1/2026